Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effects
The secretome of immune cells is currently a major focus in both diagnostic and therapeutic contexts. Cell-free therapeutic agents attract even more attention in cancer immunotherapy research, as their properties are comparable to, and sometimes surpass, those of cell-based immunotherapy. This is pa...
Saved in:
| Main Authors: | Tikhon Redkin, Victoria Turubanova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1586892/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancer
by: Zhongqiang Fan, et al.
Published: (2025-06-01) -
Sulfafurazole dimers potentiate chemo-immunotherapy of low immunogenic breast cancer by preventing the PD-L1 exosomes secretion
by: Zheng Wang, et al.
Published: (2025-05-01) -
Molecular engines driving biogenesis, trafficking and release of exosomes: SNARE proteins
by: Damilola Ogungbemi, et al.
Published: (2025-12-01) -
How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years?
by: Yu-Long Deng, et al.
Published: (2025-12-01) -
Extracellular vesicles derived from Schwann cells to enhance bone and dental tissue regeneration: a literature review
by: Xinyi Li, et al.
Published: (2025-07-01)